Small lab study finds cannabis affected simulated driving and confidence

Inhaled cannabis and oral alcohol: driving performance and subjective driving confidence in a human laboratory study.

Psychopharmacology • • Highly Relevant
🤖

AI Summary

This randomized, double-blind, placebo-controlled human laboratory study tested inhaled cannabis and oral alcohol on simulated driving and participants’ confidence in their driving. It included 9 healthy cannabis users who completed five sessions, comparing placebo with inhaled doses of 0, 15, or 30 mg THC, a 15 mg THC + 7.5 mg CBD combination, and oral alcohol. Testing continued for 7.5 hours after administration.

Alcohol impaired simulated driving measures, including lateral control. Cannabis also affected driving performance: it reduced brake force and altered headway distance while navigating obstacles. All active cannabis and alcohol conditions lowered participants’ confidence about driving, while 30 mg THC and alcohol increased reported impairment and sedation. The findings suggest cannabis affected driving performance, though not as profoundly as alcohol in this study. This abstract-based summary is limited by the small sample and simulated setting; it cannot establish the effects on real-world crashes or driving across broader populations.

💡 Key Findings

1
Oral alcohol impaired simulated driving performance, including lateral control.
High
85%
2
Inhaled THC reduced brake force and altered headway distance during obstacle navigation.
High
85%
3
All active cannabis and alcohol conditions reduced participants’ driving confidence; the highest THC dose and alcohol also increased reported impairment and sedation.
High
85%
4
The study concluded that cannabis did not cause profound alcohol-like impairment, but still negatively affected simulated driving performance.
High
80%

📄 Original Abstract

RATIONALE: Cannabis is the most commonly detected drug (second only to alcohol) among crash-involved drivers. Determining cannabis effects on driving performance is imperative to public health. OBJECTIVES: The aim of this study was to assess a range of inhaled cannabis doses and an intoxicating dose of oral alcohol on simulated driving outcomes and subjective driving confidence. METHODS: Healthy participants who used cannabis (n = 9) were enrolled in this within-subject, randomized, double-blind, double-dummy, placebo-controlled, outpatient human laboratory study. Participants completed five experimental sessions to examine the effects of inhaled cannabis (0, 15, 30 mg THC; 15 mg THC + 7.5 mg CBD) and oral alcohol (0, 0.8 g/kg [15% less for women]). Data were collected at baseline and for 7.5 h after drug administration. RESULTS: Alcohol produced robust impairment on simulated driving performance outcomes (e.g., decreased lateral control; p<0.05). Cannabis decreased brake force and altered headway distance during obstacle navigation (p<0.05). All active doses of cannabis and alcohol decreased driving confidence (e.g., willingness to operate a real vehicle; p<0.05) and increased ratings of abuse potential (e.g., drug liking, p<0.05). High dose cannabis (30 mg) and alcohol increased subjective ratings of impairment and sedation (p<0.05). CONCLUSIONS: Cannabis did not produce profound alcohol-like driving impairment; however, it was not without risk, and driving impairment was evident. All active cannabis doses decreased participants' driving confidence, while the highest dose of cannabis (30 mg) and alcohol increased self-reported impairment and sedation. Overall, even in a sample of near-daily cannabis users, cannabis negatively impacted driving performance, decreased driving acuity, and reduced confidence in safe driving ability.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.